ESTIMATED
06/20/2024
06/20/2024
(AS OF MARCH 31)
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | -$0.18 | -$0.18 | -$0.18 |
Q2 2024 | 1 | -$0.32 | -$0.02 | -$0.17 |
Q3 2024 | 0 | -$0.14 | -$0.14 | -$0.14 |
Q4 2024 | 0 | -$0.15 | -$0.15 | -$0.15 |
Q1 2025 | 0 | -$0.04 | -$0.04 | -$0.04 |
Q2 2025 | 0 | -$0.02 | -$0.02 | -$0.02 |
Q3 2025 | 0 | $0.04 | $0.04 | $0.04 |
Q4 2025 | 0 | $0.05 | $0.05 | $0.05 |
Q1 2026 | 0 | $0.06 | $0.06 | $0.06 |
Q2 2026 | 0 | $0.05 | $0.05 | $0.05 |
Q3 2026 | 0 | $0.11 | $0.11 | $0.11 |
Q4 2026 | 0 | $0.12 | $0.12 | $0.12 |
Q1 2027 | 0 | $0.12 | $0.12 | $0.12 |
Aurora Cannabis Inc. last posted its earnings results on Thursday, June 20th, 2024. The company reported $0.11 earnings per share for the quarter, topping analysts' consensus estimates of $-0.18 by $0.29. The company had revenue of 67.41 M for the quarter and had revenue of 270.28 M for the year. Aurora Cannabis Inc. has generated $-1 earnings per share over the last year ($-1.46 diluted earnings per share) and currently has a price-to-earnings ratio of -0.48. Aurora Cannabis Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 03/30/2024 | Q3 2023 | -$0.37 | $51.34 M | $67.41 M | 12/30/2023 | Q2 2023 | -$0.52 | $47.82 M | $64.42 M | 11/09/2023 | Q1 2023 | -$0.50 | -$0.06 | 0.44 | $46.44 M | $63.42 M | 08/10/2023 | Q4 2022 | -$0.80 | -$17.50 | -16.7 | $56.86 M | $50.22 M | 03/31/2023 | Q3 2022 | $13.63 | $50.24 M | $72.13 M | 12/31/2022 | Q2 2022 | -$1.92 | $47.95 M | $61.68 M | 09/30/2022 | Q1 2022 | -$0.17 | $40.45 M | $49.26 M | 06/29/2022 | Q4 2021 | -$2.48 | $40.81 M | $50.22 M | 03/30/2022 | Q3 2021 | -$4.72 | $45.53 M | $50.43 M | 12/30/2021 | Q2 2021 | -$0.38 | $54.68 M | $60.59 M | 09/29/2021 | Q1 2021 | -$0.06 | $54.50 M | $60.11 M | 06/29/2021 | Q4 2020 | -$0.65 | $47.59 M | $54.61 M | 03/30/2021 | Q3 2020 | -$0.85 | $53.72 M | $55.16 M | 12/30/2020 | Q2 2020 | -$1.74 | $47.58 M | $67.67 M | 09/22/2020 | Q1 2020 | -$0.92 | $46.64 M | $67.81 M | 07/06/2020 | Q4 2019 | -$16.93 | $67.95 M | $72.11 M | 05/14/2020 | Q3 2019 | -$1.38 | $82.61 M | $75.52 M | 02/13/2020 | Q2 2019 | -$7.20 | -$14.18 | -6.98 | $48.70 M | $56.03 M | 11/14/2019 | Q1 2019 | -$3.60 | $0.12 | 3.72 | $575.64 M | $75.25 M | 07/18/2019 | Q4 2018 | -$0.00 | $98.94 M |
---|
A. Aurora Cannabis Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off last year's report dates.
A. In the previous quarter, Aurora Cannabis Inc. (NASDAQ:ACB) reported $0.11 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.18 by $0.29.
A. The conference call for Aurora Cannabis Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Aurora Cannabis Inc.'s latest earnings report can be read online.
A. Aurora Cannabis Inc. (NASDAQ:ACB) has a recorded annual revenue of $270.28 M.
A. Aurora Cannabis Inc. (NASDAQ:ACB) has a recorded net income of $270.28 M. Aurora Cannabis Inc. has generated $-1.46 earnings per share over the last four quarters.
A. Aurora Cannabis Inc. (NASDAQ:ACB) has a price-to-earnings ratio of -0.48 and price/earnings-to-growth ratio is -0.01.